| Aaditya Desai, DO | |
|
6 Sandra Dr, Edison, NJ 08820-1900 | |
| (732) 382-3009 | |
| Not Available |
| Full Name | Aaditya Desai |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 21 Years |
| Location | 6 Sandra Dr, Edison, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053517268 | NPI | - | NPPES |
| 036-115843 | Other | IL | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 036-115843 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Englewood Hospital And Medical Center | Englewood, NJ | Hospital |
| St Joseph's Hospital And Medical Center | Paterson, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Associates Of Englewood Pc | 1355512252 | 519 |
| Passaic River Physicians Llc | 4486041514 | 52 |
| St Josephs Medical Group Pc | 8628470325 | 200 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions, today announced the expansion of its biometric identity solutions to include support for Windows Terminal Services Remote Desktop Protocol (RDP), Citrix ICA Client platforms and for Wyse CE terminals.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
Similarly to how a picked lock gives away that someone has broken into a building, the stiffening of a structure surrounding cells in the human body can indicate that cancer is invading other tissue.
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
When Dianne Rose, D.D.S., and her partner, Anthony Paciello, D.M.D., inaugurated P&R Dental Strategies, Inc. over 20 years ago to provide third-party claim review services for national insurance companies, trade unions, self-administered corporations and other dental claims payers, they could not have imagined how far they would eventually be able to take the art of insurance claim review.
› Verified 4 days ago
| Entity Name | Emergency Physician Associates Of North Jersey P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497783419 PECOS PAC ID: 7911992326 Enrollment ID: O20040825001558 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions, today announced the expansion of its biometric identity solutions to include support for Windows Terminal Services Remote Desktop Protocol (RDP), Citrix ICA Client platforms and for Wyse CE terminals.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
Similarly to how a picked lock gives away that someone has broken into a building, the stiffening of a structure surrounding cells in the human body can indicate that cancer is invading other tissue.
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
When Dianne Rose, D.D.S., and her partner, Anthony Paciello, D.M.D., inaugurated P&R Dental Strategies, Inc. over 20 years ago to provide third-party claim review services for national insurance companies, trade unions, self-administered corporations and other dental claims payers, they could not have imagined how far they would eventually be able to take the art of insurance claim review.
› Verified 4 days ago
| Entity Name | Rutgers Health-rwj Family Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780766527 PECOS PAC ID: 9032174271 Enrollment ID: O20041130000005 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions, today announced the expansion of its biometric identity solutions to include support for Windows Terminal Services Remote Desktop Protocol (RDP), Citrix ICA Client platforms and for Wyse CE terminals.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
Similarly to how a picked lock gives away that someone has broken into a building, the stiffening of a structure surrounding cells in the human body can indicate that cancer is invading other tissue.
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
When Dianne Rose, D.D.S., and her partner, Anthony Paciello, D.M.D., inaugurated P&R Dental Strategies, Inc. over 20 years ago to provide third-party claim review services for national insurance companies, trade unions, self-administered corporations and other dental claims payers, they could not have imagined how far they would eventually be able to take the art of insurance claim review.
› Verified 4 days ago
| Entity Name | Rutgers Health-rwj Pediatric Critical Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780766527 PECOS PAC ID: 1355390287 Enrollment ID: O20050119000070 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions, today announced the expansion of its biometric identity solutions to include support for Windows Terminal Services Remote Desktop Protocol (RDP), Citrix ICA Client platforms and for Wyse CE terminals.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
Similarly to how a picked lock gives away that someone has broken into a building, the stiffening of a structure surrounding cells in the human body can indicate that cancer is invading other tissue.
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
When Dianne Rose, D.D.S., and her partner, Anthony Paciello, D.M.D., inaugurated P&R Dental Strategies, Inc. over 20 years ago to provide third-party claim review services for national insurance companies, trade unions, self-administered corporations and other dental claims payers, they could not have imagined how far they would eventually be able to take the art of insurance claim review.
› Verified 4 days ago
| Entity Name | Rutgers Health-rwj Emergency Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952332546 PECOS PAC ID: 8022053800 Enrollment ID: O20050622000735 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions, today announced the expansion of its biometric identity solutions to include support for Windows Terminal Services Remote Desktop Protocol (RDP), Citrix ICA Client platforms and for Wyse CE terminals.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
Similarly to how a picked lock gives away that someone has broken into a building, the stiffening of a structure surrounding cells in the human body can indicate that cancer is invading other tissue.
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
When Dianne Rose, D.D.S., and her partner, Anthony Paciello, D.M.D., inaugurated P&R Dental Strategies, Inc. over 20 years ago to provide third-party claim review services for national insurance companies, trade unions, self-administered corporations and other dental claims payers, they could not have imagined how far they would eventually be able to take the art of insurance claim review.
› Verified 4 days ago
| Entity Name | Southern Bank Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629205844 PECOS PAC ID: 9436202421 Enrollment ID: O20090810000269 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions, today announced the expansion of its biometric identity solutions to include support for Windows Terminal Services Remote Desktop Protocol (RDP), Citrix ICA Client platforms and for Wyse CE terminals.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
Similarly to how a picked lock gives away that someone has broken into a building, the stiffening of a structure surrounding cells in the human body can indicate that cancer is invading other tissue.
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
When Dianne Rose, D.D.S., and her partner, Anthony Paciello, D.M.D., inaugurated P&R Dental Strategies, Inc. over 20 years ago to provide third-party claim review services for national insurance companies, trade unions, self-administered corporations and other dental claims payers, they could not have imagined how far they would eventually be able to take the art of insurance claim review.
› Verified 4 days ago
| Entity Name | Garden State Healthcare Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700014545 PECOS PAC ID: 8426190687 Enrollment ID: O20100126000693 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions, today announced the expansion of its biometric identity solutions to include support for Windows Terminal Services Remote Desktop Protocol (RDP), Citrix ICA Client platforms and for Wyse CE terminals.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
Similarly to how a picked lock gives away that someone has broken into a building, the stiffening of a structure surrounding cells in the human body can indicate that cancer is invading other tissue.
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
When Dianne Rose, D.D.S., and her partner, Anthony Paciello, D.M.D., inaugurated P&R Dental Strategies, Inc. over 20 years ago to provide third-party claim review services for national insurance companies, trade unions, self-administered corporations and other dental claims payers, they could not have imagined how far they would eventually be able to take the art of insurance claim review.
› Verified 4 days ago
| Entity Name | St. Joseph's Emergency Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568791192 PECOS PAC ID: 5092996181 Enrollment ID: O20110223000002 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions, today announced the expansion of its biometric identity solutions to include support for Windows Terminal Services Remote Desktop Protocol (RDP), Citrix ICA Client platforms and for Wyse CE terminals.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
Similarly to how a picked lock gives away that someone has broken into a building, the stiffening of a structure surrounding cells in the human body can indicate that cancer is invading other tissue.
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
When Dianne Rose, D.D.S., and her partner, Anthony Paciello, D.M.D., inaugurated P&R Dental Strategies, Inc. over 20 years ago to provide third-party claim review services for national insurance companies, trade unions, self-administered corporations and other dental claims payers, they could not have imagined how far they would eventually be able to take the art of insurance claim review.
› Verified 4 days ago
| Entity Name | Medical Associates Of Englewood Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952681918 PECOS PAC ID: 1355512252 Enrollment ID: O20110927000020 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions, today announced the expansion of its biometric identity solutions to include support for Windows Terminal Services Remote Desktop Protocol (RDP), Citrix ICA Client platforms and for Wyse CE terminals.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
Similarly to how a picked lock gives away that someone has broken into a building, the stiffening of a structure surrounding cells in the human body can indicate that cancer is invading other tissue.
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
When Dianne Rose, D.D.S., and her partner, Anthony Paciello, D.M.D., inaugurated P&R Dental Strategies, Inc. over 20 years ago to provide third-party claim review services for national insurance companies, trade unions, self-administered corporations and other dental claims payers, they could not have imagined how far they would eventually be able to take the art of insurance claim review.
› Verified 4 days ago
| Entity Name | Desjet Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346694114 PECOS PAC ID: 7618263450 Enrollment ID: O20160906000443 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions, today announced the expansion of its biometric identity solutions to include support for Windows Terminal Services Remote Desktop Protocol (RDP), Citrix ICA Client platforms and for Wyse CE terminals.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
Similarly to how a picked lock gives away that someone has broken into a building, the stiffening of a structure surrounding cells in the human body can indicate that cancer is invading other tissue.
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
When Dianne Rose, D.D.S., and her partner, Anthony Paciello, D.M.D., inaugurated P&R Dental Strategies, Inc. over 20 years ago to provide third-party claim review services for national insurance companies, trade unions, self-administered corporations and other dental claims payers, they could not have imagined how far they would eventually be able to take the art of insurance claim review.
› Verified 4 days ago
| Entity Name | St Josephs Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205425519 PECOS PAC ID: 8628470325 Enrollment ID: O20210716000520 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions, today announced the expansion of its biometric identity solutions to include support for Windows Terminal Services Remote Desktop Protocol (RDP), Citrix ICA Client platforms and for Wyse CE terminals.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
Similarly to how a picked lock gives away that someone has broken into a building, the stiffening of a structure surrounding cells in the human body can indicate that cancer is invading other tissue.
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
When Dianne Rose, D.D.S., and her partner, Anthony Paciello, D.M.D., inaugurated P&R Dental Strategies, Inc. over 20 years ago to provide third-party claim review services for national insurance companies, trade unions, self-administered corporations and other dental claims payers, they could not have imagined how far they would eventually be able to take the art of insurance claim review.
› Verified 4 days ago
| Entity Name | Passaic River Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962162644 PECOS PAC ID: 4486041514 Enrollment ID: O20220420000861 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions, today announced the expansion of its biometric identity solutions to include support for Windows Terminal Services Remote Desktop Protocol (RDP), Citrix ICA Client platforms and for Wyse CE terminals.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
Similarly to how a picked lock gives away that someone has broken into a building, the stiffening of a structure surrounding cells in the human body can indicate that cancer is invading other tissue.
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
When Dianne Rose, D.D.S., and her partner, Anthony Paciello, D.M.D., inaugurated P&R Dental Strategies, Inc. over 20 years ago to provide third-party claim review services for national insurance companies, trade unions, self-administered corporations and other dental claims payers, they could not have imagined how far they would eventually be able to take the art of insurance claim review.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aaditya Desai, DO 6 Sandra Dr, Edison, NJ 08820-1900 Ph: () - | Aaditya Desai, DO 6 Sandra Dr, Edison, NJ 08820-1900 Ph: (732) 382-3009 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions, today announced the expansion of its biometric identity solutions to include support for Windows Terminal Services Remote Desktop Protocol (RDP), Citrix ICA Client platforms and for Wyse CE terminals.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
Similarly to how a picked lock gives away that someone has broken into a building, the stiffening of a structure surrounding cells in the human body can indicate that cancer is invading other tissue.
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
When Dianne Rose, D.D.S., and her partner, Anthony Paciello, D.M.D., inaugurated P&R Dental Strategies, Inc. over 20 years ago to provide third-party claim review services for national insurance companies, trade unions, self-administered corporations and other dental claims payers, they could not have imagined how far they would eventually be able to take the art of insurance claim review.
› Verified 4 days ago
Michael D. Cali, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 65 James St, Edison, NJ 08820 Phone: 732-321-7000 | |
Amarpal Kaur Purewal, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 65 James St, Edison, NJ 08820 Phone: 732-321-7000 Fax: 732-744-5614 | |
Dr. Ryan Davidson Hill, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 65 James St, Edison, NJ 08820 Phone: 732-321-7000 | |
Aynur A. Devli, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 65 James St, Edison, NJ 08820 Phone: 732-321-7000 Fax: 732-744-5614 | |
Shilpa K Amin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 166 Winthrop Rd, Edison, NJ 08817 Phone: 347-678-0963 | |
Ofunne Obaze, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 65 James St, Edison, NJ 08820 Phone: 732-321-7000 Fax: 732-744-5614 |